Showdowns
Sub-Par Soderbergh
(Weekly Gross / Weekly End Date (Thu) / Weekly Rank / Theaters / Theater Avg. / % Last Wk / Gross-to-Date)
| WEEK NUMBER |
![]() Solaris |
![]() The Informant! |
![]() Haywire |
![]() Side Effects |
| 1 | $8,201,282 12-5-02 / 7 2,406 / 2,406 +207.6% $10,867,224 |
$14,076,861 9-24-09 / 2 2,505 / 2,505 - $14,076,861 |
$11,279,202 1-26-12 / 5 2,439 / 2,439 - $11,279,202 |
$12,820,836 2-14-13 / 3 2,605 / 2,605 - $12,820,836 |
| 2 | $3,162,063 12-12-02 / 11 2,353 / 2,353 -61.4% $14,029,287 |
$8,703,235 10-1-09 / 4 2,505 / 2,505 -38.2% $22,780,096 |
$5,365,702 2-2-12 / 10 2,441 / 2,441 -52.4% $16,644,904 |
$8,921,680 2-21-13 / 8 2,605 / 2,605 -30.4% $21,742,516 |
| ADVERTISEMENT (scroll to continue with chart) | ||||
| 3 | $701,148 12-19-02 / 22 409 / 409 -77.8% $14,730,435 |
$4,863,052 10-8-09 / 9 2,425 / 2,425 -44.1% $27,643,148 |
$1,730,105 2-9-12 / 18 1,251 / 1,251 -67.8% $18,375,009 |
$4,581,793 2-28-13 / 10 2,070 / 2,070 -48.6% $26,324,309 |
| 4 | $77,756 12-26-02 / 53 74 / 74 -88.9% $14,808,191 |
$3,168,292 10-15-09 / 11 2,202 / 2,202 -34.8% $30,811,440 |
$306,735 2-16-12 / 37 263 / 263 -82.3% $18,681,744 |
$2,377,361 3-7-13 / 15 1,112 / 1,112 -48.1% $28,701,670 |
| 5 | $39,294 1-2-03 / 70 56 / 56 -49.5% $14,847,485 |
$1,274,527 10-22-09 / 13 1,228 / 1,228 -59.8% $32,085,967 |
$105,350 2-23-12 / 52 79 / 79 -65.7% $18,787,094 |
$1,237,543 3-14-13 / 18 602 / 602 -47.9% $29,939,213 |
| 6 | $23,774 1-9-03 / 74 41 / 41 -39.5% $14,871,259 |
$459,130 10-29-09 / 21 287 / 287 -64% $32,545,097 |
$55,967 3-1-12 / 60 37 / 37 -46.9% $18,843,061 |
$771,898 3-21-13 / 17 402 / 402 -37.6% $30,711,111 |
| 7 | $16,616 1-16-03 / 76 22 / 22 -30.1% $14,887,875 |
$273,699 11-5-09 / 24 220 / 220 -40.4% $32,818,796 |
$13,749 3-8-12 / 78 32 / 32 -75.4% $18,856,810 |
$396,393 3-28-13 / 24 225 / 225 -48.6% $31,107,504 |
| 8 | $10,203 1-23-03 / 85 18 / 18 -38.6% $14,898,078 |
$147,015 11-12-09 / 36 138 / 138 -46.3% $32,965,811 |
$63,785 3-15-12 / 59 82 / 82 +363.9% $18,920,595 |
$179,425 4-4-13 / 34 102 / 102 -54.7% $31,286,929 |
| 9 | $12,824 1-30-03 / 82 20 / 20 +25.7% $14,910,901 |
$185,591 11-19-09 / 26 247 / 247 +26.2% $33,151,402 |
$21,801 3-22-12 / 72 69 / 69 -65.8% $18,942,396 |
$139,431 4-11-13 / 38 80 / 80 -22.3% $31,426,360 |
| 10 | $44,173 2-6-03 / 55 26 / 26 +244.5% $14,955,075 |
$91,657 11-26-09 / 42 92 / 92 -50.6% $33,243,059 |
- | $76,470 4-18-13 / 46 53 / 53 -45.2% $31,502,830 |
| 11 | $18,307 2-13-03 / 80 20 / 20 -58.6% $14,973,382 |
$48,081 12-3-09 / 51 62 / 62 -47.5% $33,291,140 |
- | $443,303 4-25-13 / 22 645 / 645 +479.7% $31,946,133 |
| 12 | - | $16,671 12-10-09 / 61 40 / 40 -65.3% $33,307,811 |
- | $73,745 5-2-13 / 45 108 / 108 -83.4% $32,019,878 |
| 13 | - | $9,010 12-17-09 / 67 18 / 18 -46% $33,316,821 |
- | $99,170 5-9-13 / 36 165 / 165 +34.5% $32,119,048 |
| Total | $14,973,382 | $33,316,821 | $18,942,396 | $32,172,757 |
| Budget | $47 million | $22 million | $23 million | n/a |
| Theaters | 2,406 | 2,505 | 2,441 | 2,605 |
| Release Date |
11/27/02 | 09/18/09 | 01/20/12 | 02/08/2013 |
| Yearly Rank |
124 | 84 | 110 | 27 |
| All Time Rank |
3,320 | 1,986 | 2,920 | 2,052 |

Facebook
Twitter


